NRX Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
NRXP
CUSIP
629444209
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 629444209 since 12/18/2024, largest first.

Filer % of Class Filed
B Group, Inc. 13G
12.6% 8/21/2025
Event 8/18/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Anson Funds Management LP 13G/A
4.9% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 52 11.6 M $47.6 M
2026 Q1 39 6.21 M $13.2 M
2025 Q4 31 5.24 M $14.2 M
2025 Q3 28 3.96 M $13.0 M
2025 Q2 26 2.99 M $9.76 M
2025 Q1 24 2.26 M $4.60 M
2024 Q4 28 1.05 M $2.31 M
2024 Q3 23 714 k $1.21 M
2024 Q2 25 525 k $1.30 M